Dolby Laboratories, Inc. (NYSE:DLB) Shares Acquired by Boston Trust Walden Corp

Boston Trust Walden Corp raised its position in Dolby Laboratories, Inc. (NYSE:DLB - Free Report) by 0.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,084,700 shares of the electronics maker's stock after purchasing an additional 9,624 shares during the quarter. Boston Trust Walden Corp owned about 1.14% of Dolby Laboratories worth $84,715,000 as of its most recent SEC filing.

Several other hedge funds have also made changes to their positions in DLB. Willis Investment Counsel grew its holdings in shares of Dolby Laboratories by 3.5% during the 4th quarter. Willis Investment Counsel now owns 6,157 shares of the electronics maker's stock worth $481,000 after purchasing an additional 206 shares during the period. Diversified Investment Strategies LLC boosted its stake in Dolby Laboratories by 0.3% during the fourth quarter. Diversified Investment Strategies LLC now owns 59,395 shares of the electronics maker's stock worth $4,639,000 after buying an additional 195 shares during the period. Pacer Advisors Inc. increased its position in shares of Dolby Laboratories by 211.8% during the fourth quarter. Pacer Advisors Inc. now owns 41,223 shares of the electronics maker's stock valued at $3,220,000 after acquiring an additional 28,001 shares during the last quarter. KBC Group NV raised its stake in shares of Dolby Laboratories by 56.4% in the 4th quarter. KBC Group NV now owns 2,476 shares of the electronics maker's stock valued at $193,000 after acquiring an additional 893 shares during the period. Finally, Blue Trust Inc. lifted its holdings in shares of Dolby Laboratories by 14.7% in the 4th quarter. Blue Trust Inc. now owns 1,587 shares of the electronics maker's stock worth $121,000 after acquiring an additional 203 shares during the last quarter. Hedge funds and other institutional investors own 58.56% of the company's stock.

Insider Buying and Selling at Dolby Laboratories

In related news, EVP Mark Andrew Sherman sold 40,000 shares of the company's stock in a transaction that occurred on Thursday, January 30th. The stock was sold at an average price of $84.88, for a total value of $3,395,200.00. Following the completion of the transaction, the executive vice president now directly owns 62,397 shares of the company's stock, valued at $5,296,257.36. This represents a 39.06 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CAO Ryan Nicholson sold 10,500 shares of the stock in a transaction that occurred on Tuesday, November 26th. The shares were sold at an average price of $80.18, for a total transaction of $841,890.00. Following the completion of the transaction, the chief accounting officer now owns 24,364 shares in the company, valued at $1,953,505.52. This represents a 30.12 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 182,917 shares of company stock valued at $14,861,429 in the last quarter. Corporate insiders own 38.39% of the company's stock.

Dolby Laboratories Stock Up 0.1 %

DLB stock traded up $0.05 during midday trading on Thursday, hitting $84.50. The company's stock had a trading volume of 392,207 shares, compared to its average volume of 485,379. The firm has a 50-day simple moving average of $79.76 and a 200-day simple moving average of $75.87. The firm has a market capitalization of $8.06 billion, a P/E ratio of 31.07 and a beta of 0.98. Dolby Laboratories, Inc. has a 52-week low of $66.35 and a 52-week high of $89.66.

Dolby Laboratories Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, February 19th. Shareholders of record on Tuesday, February 11th will be issued a dividend of $0.33 per share. The ex-dividend date is Tuesday, February 11th. This represents a $1.32 annualized dividend and a yield of 1.56%. Dolby Laboratories's dividend payout ratio (DPR) is 48.53%.

Wall Street Analysts Forecast Growth

Several analysts recently weighed in on DLB shares. StockNews.com downgraded shares of Dolby Laboratories from a "strong-buy" rating to a "buy" rating in a report on Friday, January 31st. Barrington Research reaffirmed an "outperform" rating and issued a $100.00 price objective on shares of Dolby Laboratories in a research note on Monday, January 27th. Finally, Rosenblatt Securities reiterated a "buy" rating and issued a $100.00 price objective on shares of Dolby Laboratories in a report on Thursday, January 30th.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.